Matthew Shinkle

3 weeks ago | healio.com | Matthew Shinkle

Key takeaways: Adding niraparib to abiraterone acetate and prednisone lowered risk for cancer growth by 37% among certain patients with prostate cancer. Patients with BRCA1/2 mutations had a 48% risk reduction. CHICAGO — Adding niraparib to abiraterone acetate and prednisone may help slow cancer growth for patients with metastatic castration-sensitive prostate cancer with homologous recombination repair gene alterations.

3 weeks ago | healio.com | Matthew Shinkle

Key takeaways: Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk for recurrence than patients given educational materials. They also had 37% lower risk for death. CHICAGO — A structured exercise program after surgery and adjuvant chemotherapy reduced the risk for cancer recurrence and death for certain patients with colon cancer, according to study results presented at ASCO Annual Meeting.

3 weeks ago | healio.com | Matthew Shinkle

Key takeaways: Patients who received usual care plus telephone-based weekly symptom assessments had 53% lower odds of ED use. The intervention also yielded net cost savings of about $12,000 per patient. CHICAGO — A weekly symptom-assessment intervention led by trained lay health workers may help reduce acute care use and improve end-of-life care for older adults with cancer, according to data presented at ASCO Annual Meeting.

3 weeks ago | healio.com | Matthew Shinkle

Key takeaways: Use of an electronic patient-reported outcome-based program did not significantly reduce ED or inpatient visits after cancer treatment. Only 51% of patients used the program to report symptoms. CHICAGO — Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not significantly reduce ED or inpatient admission events after cancer treatment, according to research.

4 weeks ago | healio.com | Matthew Shinkle

Key takeaways: The app improved quality of life, caregiving burden, depression and PTSD symptoms, and coping skills among caregivers of patients undergoing HSCT. A multisite trial is planned to assess the app’s scalability. CHICAGO — Use of a psychosocial digital app improved quality of life, caregiving burden, depression and PTSD symptoms, and coping skills for caregivers of patients undergoing hematopoietic stem cell transplantation, according to research.